Chrysostomi Gialeli
11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2021
-
Mark
Extracellular matrix: paving the way to the newest trends in atherosclerosis
- Contribution to journal › Article
- 2019
-
Mark
Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling
- Contribution to journal › Article
- 2018
-
Mark
Novel potential inhibitors of complement system and their roles in complement regulation and beyond
- Contribution to journal › Article
- 2016
-
Mark
Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.
(2016) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 91(May). p.42-57
- Contribution to journal › Scientific review
-
Mark
Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
- Contribution to journal › Article
- 2015
-
Mark
Extracellular matrix structure.
(2015) In Advanced Drug Delivery Reviews
- Contribution to journal › Scientific review
- 2013
-
Mark
Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells
- Contribution to journal › Article
-
Mark
Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease
- Contribution to journal › Article
- « previous
- 1
- 2
- next »
